Bionyra Pharma
Developing next-generation biologics for severe immunological and inflammatory diseases
$165MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Developing next-generation biologics for severe immunological and inflammatory diseases
Builds AI architecture fusing biological data modalities to accelerate pharma and biotech drug development
Develops AI-powered prenatal ultrasound platform for expert-level fetal heart screening and conge...
Pitching Sofinnova Partners? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room